Pharma-Bio Serv, Inc. (PBSV)
OTCMKTS: PBSV · Delayed Price · USD
0.750
+0.015 (2.03%)
May 3, 2024, 10:53 AM EDT - Market closed

Pharma-Bio Serv Revenue

Pharma-Bio Serv had revenue of $15.12M in the twelve months ending January 31, 2024, down -18.80% year-over-year. Revenue in the quarter ending January 31, 2024 was $2.38M, a -43.84% decrease year-over-year. In the fiscal year ending October 31, 2023, Pharma-Bio Serv had annual revenue of $16.98M, a decrease of -12.48%.

Revenue (ttm)
$15.12M
Revenue Growth
-18.80%
P/S Ratio
1.14
Revenue / Employee
$151,187
Employees
100
Market Cap
17.22M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Oct 31, 202316.98M-2.42M-12.48%
Oct 31, 202219.40M-716.45K-3.56%
Oct 31, 202120.12M-1.45M-6.72%
Oct 31, 202021.56M2.06M10.55%
Oct 31, 201919.51M1.71M9.61%
Oct 31, 201817.80M2.22M14.24%
Oct 31, 201715.58M-3.96M-20.26%
Oct 31, 201619.54M-3.85M-16.46%
Oct 31, 201523.38M-4.17M-15.13%
Oct 31, 201427.56M-5.51M-16.66%
Oct 31, 201333.06M3.83M13.12%
Oct 31, 201229.23M9.29M46.63%
Oct 31, 201119.93M8.59M75.68%
Oct 31, 201011.35M-132.63K-1.16%
Oct 31, 200911.48M-3.72M-24.46%
Oct 31, 200815.20M-1.01M-6.22%
Oct 31, 200716.20M1.98M13.88%
Oct 31, 200614.23M14.22M142,198.31%
Jun 30, 200510.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 371.62B
Johnson & Johnson 81.80B
Merck & Co. 60.12B
AbbVie 54.40B
Novartis AG 49.92B
AstraZeneca 47.61B
Thermo Fisher 42.49B
Abbott Laboratories 40.33B
Revenue Rankings